Carbapenem resistance in Pseudomonas aeruginosa from cystic fibrosis patients

Journal of Antimicrobial Chemotherapy

Volumn 38, Issue 1, 1996, Pages 39-45

  Ballestero, S ^a   Fernandez Rodriguez A ^a   Villaverde, R ^a   Escobar, H ^a   Perez Diaz J C ^a   Baquero, F ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CARBAPENEM DERIVATIVE; IMIPENEM; THIENAMYCIN DERIVATIVE;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BIOSYNTHESIS; CHILD; CLINICAL TRIAL; CYSTIC FIBROSIS; DRUG EFFECT; ENZYMOLOGY; EVALUATION; GENETICS; HUMAN; INFANT; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; NEWBORN; PHENOTYPE; PRESCHOOL CHILD; PSEUDOMONAS AERUGINOSA; SPECIES DIFFERENCE;

ADOLESCENT; ADULT; BETA-LACTAMASES; CARBAPENEMS; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DRUG RESISTANCE, MICROBIAL; EVALUATION STUDIES; HUMANS; IMIPENEM; INFANT; INFANT, NEWBORN; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; PSEUDOMONAS AERUGINOSA; SPECIES SPECIFICITY; THIENAMYCINS;

EID: 0030178786     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/38.1.39     Document Type: Article

References (20)

1. Aubert, G., Pozzeto, B. & Dorche, G. (1992). Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy. Journal of Antimicrobial Chemotherapy 29, 307-12.
2. Ballestero, S., Escobar, H., Villaverde, R., Elía, M., Ojeda-Vargas, M. & Baquero, F. (1993). Continuous monitoring of antimicrobial resistance in cystic fibrosis patients. In Clinical Ecology of Cystic Fibrosis, 1st edn (Escobar, H., Baquero, F., Suárez, L., Eds), pp. 63-72. Excerpta Medica, International Congress series 1034, Madrid.
3. Courcol, R. J., Pinkas, M. & Martin, G. R. (1989). A seven year survey of antibiotic susceptibility and its relationship with usage. Journal of Antimicrobial Chemotherapy 23, 441-51.
4. Filip, C., Fletcher, G., Wulff, J. L. & Earhart C. F. (1973). Solubilization of the cytoplasmic membrane of Escherichia coli by the ionic detergent sodium-lauryl sarcosinate. Journal of Bacteriology 115, 717-22.
5. Fukuda, H., Hosaka, K., Hirai, K. & Iyobe, S. (1990). New norfloxacin resistance gene in Pseudomonas aeruginosa PAO. Antimicrobial Agents and Chemotherapy 34, 1757-61.
6. Knight, R. R. K., Pillai, S. (1993). Meropenem for the treatment of cystic fibrosis in named patients. In Clinical Ecology of Cystic Fibrosis, 1st edn (Escobar, H., Baquero, F., Suárez, L., Eds), pp. 125-130. Excerpta Medica, International Congress series 1034, Madrid.
7. Krilov, L. R., Blumer, J. L., Stern, R. C., Hartstein, A. I., Iglewski, B. N., Goldmann, D. A. (1985). Imipenem/cilastatin in acute pulmonary exacerbations of cystic fibrosis. Review of Infectious Diseases 7, Suppl., 482-9.
8. Livermore, D. M. (1992). Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 36, 2046-8.
9. Meyers, M. G., Koontz, F. P. & Weinberger, M. (1983). Lower respiratory infections in patients with cystic fibrosis. In Textbook of Cystic Fibrosis (Lloyd-Still, J. D., Ed.), pp. 91-107.
10. National Committee for Clinical Laboratory Standards. (1991). Performance Standards for Antimicrobial Susceptibility Testing: Approved Standard 11, No 17. NCCLS, Vilanova, PA.
11. O'Rourke, E. J., Lambert, K. G., Parsonet, K. C., Macone, A. B. & Goldmann, D. A. (1991). False resistance to imipenem with a microdilution susceptibility testing system. Journal of Clinical Microbiology 29, 827-9.
12. Pedersen, S. S., Pressler, T., Hoiby, N., Bentzon, M. W. & Koch, C. (1985). Imipenem/cilastatin treatment of multiresistant Pseudomonas aeruginosa lung infection in cystic fibrosis. Journal of Antimicrobial Chemotherapy 16, 629-35.
13. Quinn, J. P., Studemeister, A. E., DiVincenzo, C. A. & Lerner, S. A. (1988). Resistance to imipenem in Pseudomonas aeruginosa: clinical experience and biochemical mechanisms. Reviews of Infectious Disease 10, 892-8.
14. Tally, F. P., Jacobs, N. V. & Gorbach, S. L. (1980). In vitro activity of N-formimidoyl thienamycin (MK0787). Antimicrobial Agents and Chemotherapy 18, 642-4.
15. Trias, J. & Nikaido, H. (1990). Protein D2 channel of the Pseudomonas aeruginosa outer membrane has a binding site for basic amino acids and peptides. Journal of Biological Chemistry 265, 15680-4.
16. Watanabe, M., Iyobe, S., Inoue, M. & Mitsuhashi, S. (1991). Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 35, 147-51.
17. White, R. L., Kays, M. B., Friederich, L. V., Brown, E. W. & Koonce, J. R. (1991). Pseudoresistance of Pseudomonas aeruginosa resulting from degradation of imipenem in an automated susceptibility testing system with predried panels. Journal of Clinical Microbiology 29, 398-400.
18. Wong, K., Roberts, M., Owens, L., Fife, M. & Smith, A. (1984). Selective media for the quantitation of bacteria in CF sputum. Journal of Medical Microbiology 17, 113-9.
19. Yang, Y. & Livermore, D. M. (1989). Interactions of meropenem with class I chromosomal beta-lactamases. Journal of Antimicrobial Chemotherapy 24, Suppl. A, 207-17.
20. Zhou, X. Y., Kitzis, M. & Gutmann, L. (1993). Role of cephalosporinase in carbapenem resistance of clinical isolates of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 37, 387-9.